330 related articles for article (PubMed ID: 15865876)
1. Karyotype and molecular cytogenetic studies in polycythemia vera.
Andrieux JL; Demory JL
Curr Hematol Rep; 2005 May; 4(3):224-9. PubMed ID: 15865876
[TBL] [Abstract][Full Text] [Related]
2. [Cytogenetics and molecular genetics in myelofibrosis with myeloid metaplasia and polycythemia vera].
Roche-Lestienne C; Andrieux J
Pathol Biol (Paris); 2007 Feb; 55(1):49-55. PubMed ID: 16901657
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic findings in polycythemia vera: a review and reevaluation.
Meytes D; Akstein E; Modan B
Isr J Med Sci; 1977 Dec; 13(12):1226-39. PubMed ID: 599002
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic studies in polycythemia vera.
Jarosová M; Indrák K; Dusek J; Kapustová M
Neoplasma; 1988; 35(2):221-8. PubMed ID: 3374710
[TBL] [Abstract][Full Text] [Related]
5. Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2.
Hélias C; Struski S; Gervais C; Leymarie V; Mauvieux L; Herbrecht R; Lessard M
Cancer Genet Cytogenet; 2008 Jan; 180(1):51-5. PubMed ID: 18068534
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics of agnogenic myeloid metaplasia: a study of 61 patients.
Djordjevic V; Dencic-Fekete M; Jovanovic J; Bizic S; Jankovic G; Bogdanovic A; Cemerikic-Martinovic V; Gotic M
Cancer Genet Cytogenet; 2007 Feb; 173(1):57-62. PubMed ID: 17284371
[TBL] [Abstract][Full Text] [Related]
7. Chromosome studies in 104 patients with polycythemia vera.
Diez-Martin JL; Graham DL; Petitt RM; Dewald GW
Mayo Clin Proc; 1991 Mar; 66(3):287-99. PubMed ID: 2002687
[TBL] [Abstract][Full Text] [Related]
8. Cryptic translocations involving chromosome 20 in polycythemia vera.
Busson M; Romana S; Nguyen Khac F; Bernard O; Berger R
Ann Genet; 2004; 47(4):365-71. PubMed ID: 15581834
[TBL] [Abstract][Full Text] [Related]
9. A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.
Larsen TS; Hasselbalch HC; Pallisgaard N; Kerndrup GB
Cancer Genet Cytogenet; 2007 Jan; 172(2):107-12. PubMed ID: 17213018
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
Panani AD
Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090
[TBL] [Abstract][Full Text] [Related]
11. Clonality and karyotype studies in polycythemia vera.
Tanzer J
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):167-72. PubMed ID: 8036135
[TBL] [Abstract][Full Text] [Related]
12. Karyotypic abnormalities in myelofibrosis following polycythemia vera.
Andrieux J; Demory JL; Caulier MT; Agape P; Wetterwald M; Bauters F; Laï JL
Cancer Genet Cytogenet; 2003 Jan; 140(2):118-23. PubMed ID: 12645649
[TBL] [Abstract][Full Text] [Related]
13. Myeloproliferative disorders.
Bench AJ; Cross NC; Huntly BJ; Nacheva EP; Green AR
Best Pract Res Clin Haematol; 2001 Sep; 14(3):531-51. PubMed ID: 11640868
[TBL] [Abstract][Full Text] [Related]
14. [Cytogenetic analysis in patients with polycythemia vera].
Duan LM; Li JY; Pan JL; Qiu HR; Zhang SJ; Wu YF; Xu W; Xue YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):121-4. PubMed ID: 17490536
[TBL] [Abstract][Full Text] [Related]
15. Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders.
Bacher U; Haferlach T; Schoch C
Cancer Genet Cytogenet; 2005 Jul; 160(2):179-83. PubMed ID: 15993276
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic findings in untreated patients with essential thrombocythemia.
Panani AD
In Vivo; 2006; 20(3):381-4. PubMed ID: 16724675
[TBL] [Abstract][Full Text] [Related]
17. Is the gain of 9p involved in the pathogenesis of polycythemia vera? A purpose of a case.
Zamora L; Lloveras E; Espinet B; Muñoz C; Perez C; Plaja A
Haematologica; 2002 Jan; 87(1):ECR05. PubMed ID: 11801479
[No Abstract] [Full Text] [Related]
18. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment with interferon-alpha in a case of acute myeloid leukemia with del (20q) following polycythemia vera].
Sumi M; Tauchi T; Takaku T; Ohyashiki JH; Ohyashiki K
Rinsho Ketsueki; 2005 Nov; 46(11):1208-12. PubMed ID: 16440805
[TBL] [Abstract][Full Text] [Related]
20. [Chronic myeloproliferative diseases. Clinical and cytogenetic study].
Fernández Rodríguez MN
Sangre (Barc); 1971; 16(2):159-84. PubMed ID: 5282697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
